CVS Health (CVS) Projected to Post Earnings on Tuesday

CVS Health (NYSE:CVS) is anticipated to post its Q4 2025 results before the market opens on Tuesday, February 10th. Analysts expect the company to announce earnings of $0.99 per share and revenue of $103.6718 billion for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 8:00 AM ET.

CVS Health Trading Up 2.7%

Shares of CVS stock opened at $78.38 on Friday. CVS Health has a twelve month low of $53.36 and a twelve month high of $85.15. The stock has a market cap of $99.50 billion, a price-to-earnings ratio of 206.27, a PEG ratio of 0.72 and a beta of 0.50. The company’s 50-day moving average price is $78.62 and its 200-day moving average price is $75.65. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s dividend payout ratio is 700.00%.

Hedge Funds Weigh In On CVS Health

Several institutional investors have recently modified their holdings of CVS. Legacy Advisors LLC purchased a new stake in shares of CVS Health during the third quarter worth approximately $249,000. Resurgent Financial Advisors LLC acquired a new position in shares of CVS Health in the 3rd quarter valued at $215,000. PFG Advisors purchased a new position in shares of CVS Health during the third quarter worth about $205,000. MUFG Securities EMEA plc purchased a new position in CVS Health during the 2nd quarter worth approximately $258,000. Finally, McIlrath & Eck LLC grew its position in shares of CVS Health by 422.9% during the second quarter. McIlrath & Eck LLC now owns 3,383 shares of the pharmacy operator’s stock worth $233,000 after acquiring an additional 2,736 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CVS shares. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 price target (up previously from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Wells Fargo & Company decreased their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research note on Thursday, November 13th. Barclays raised their price objective on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Mizuho upped their target price on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. Finally, Jefferies Financial Group lifted their price target on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Nineteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.82.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.